Biomedical Engineering Reference
In-Depth Information
Morales DK, Jacobs NJ, Rajamani S, Krishnamurthy M, Cubillos-Ruiz JR, Hogan DA (2010)
Antifungal mechanisms by which a novel Pseudomonas aeruginosa phenazine toxin kills
Candida albicans in biofilms. Mol Microbiol 78(6):1379-1392
Mowat E, Williams C, Jones B, McChlery S, Ramage G (2009) The characteristics of Aspergillus
fumigatus mycetoma development: is this a biofilm? Med Mycol 47(Suppl 1):S120-S126
Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA (2003) Mechanism of fluconazole resis-
tance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
Infect Immun 71(8):4333-4340
Muszkieta L, Beauvais A, Pahtz V, Gibbons JG, Anton Leberre V, Beau R, Shibuya K, Rokas A,
Francois JM, Kniemeyer O, Brakhage AA, Latge JP (2013) Investigation of Aspergillus
fumigatus biofilm formation by various “omics” approaches. Front Microbiol 4:13
Navarathna DH, Hornby JM, Krishnan N, Parkhurst A, Duhamel GE, Nickerson KW (2007) Effect
of farnesol on a mouse model of systemic candidiasis, determined by use of a DPP3 knockout
mutant of Candida albicans. Infect Immun 75(4):1609-1618
Nett J, Andes D (2006) Candida albicans biofilm development, modeling a host-pathogen inter-
action. Curr Opin Microbiol 9(4):340-345
Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, VanHandel M, Andes D (2007)
Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents
Chemother 51(2):510-520
Nobile CJ, Mitchell AP (2005) Regulation of cell-surface genes and biofilm formation by the
C. albicans transcription factor Bcr1p. Curr Biol 15(12):1150-1155
Nobile CJ, Mitchell AP (2006) Genetics and genomics of Candida albicans biofilm formation.
Cell Microbiol 8(9):1382-1391
Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, Edwards JE, Filler SG, Mitchell AP
(2006a) Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and
in vivo. PLoS Pathog 2(7):e63
Nobile CJ, Nett JE, Andes DR, Mitchell AP (2006b) Function of Candida albicans adhesin Hwp1
in biofilm formation. Eukaryot Cell 5(10):1604-1610
Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, Andes DR, Mitchell AP (2008)
Complementary adhesin function in C. albicans biofilm formation. Curr Biol 18(14):
1017-1024
Nobile CJ, Nett JE, Hernday AD, Homann OR, Deneault JS, Nantel A, Andes DR, Johnson AD,
Mitchell AP (2009) Biofilm matrix regulation by Candida albicans Zap1. PLoS Biol 7(6):
e1000133
Nobile CJ, Fox EP, Nett JE, Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR,
Johnson AD (2012) A recently evolved transcriptional network controls biofilm development
in Candida albicans. Cell 148(1-2):126-138
Odds FC, Brown AJ, Gow NA (2003) Antifungal agents: mechanisms of action. Trends Microbiol
11(6):272-279
Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH (2010) An insight into the
antifungal pipeline: selected new molecules and beyond. Nat Rev Drug Discov 9(9):719-727
Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG,
Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD (2009)
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious
Diseases Society of America. Clin Infect Dis 48(5):503-535
Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, Rinaldi MG,
Stevens DA, Graybill JR (2000) Invasive aspergillosis. Disease spectrum, treatment practices,
and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 79(4):250-260
Pereira CA, Romeiro RL, Costa AC, Machado AK, Junqueira JC, Jorge AO (2011) Susceptibility
of Candida albicans, Staphylococcus aureus, and Streptococcus mutans biofilms to photo-
dynamic inactivation: an in vitro study. Lasers Med Sci 26(3):341-348
Perlin DS (2011) Current perspectives on echinocandin class drugs. Future Microbiol 6(4):
441-457
Search WWH ::
Custom Search